Peter Rhode is Officer of HCW Biologics Inc.. Currently has a direct ownership of 77,500 shares of HCWB, which is worth approximately $54,250. The most recent transaction as insider was on Dec 11, 2023, when has been sold 14,000 shares (Common Stock) at a price of $0.14 per share, resulting in proceeds of $1,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.5K
0% 3M change
22.05% 12M change
Total Value Held $54,250

Peter Rhode Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2023
BUY
Exercise of conversion of derivative security
$1,960 $0.14 p/Share
14,000 Added 15.3%
77,500 Common Stock
Nov 17 2023
BUY
Exercise of conversion of derivative security
$2,100 $0.14 p/Share
15,000 Added 19.11%
63,500 Common Stock
Jan 14 2022
BUY
Exercise of conversion of derivative security
$309 $0.18 p/Share
1,715 Added 3.42%
48,500 Common Stock
Jul 22 2021
BUY
Open market or private purchase
$100,000 $8.0 p/Share
12,500 Added 21.08%
46,785 Common Stock
PR

Peter Rhode

Officer
Miramar, FL

Track Institutional and Insider Activities on HCWB

Follow HCW Biologics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCWB shares.

Notify only if

Insider Trading

Get notified when an Hcw Biologics Inc. insider buys or sells HCWB shares.

Notify only if

News

Receive news related to HCW Biologics Inc.

Track Activities on HCWB